Reset filter
Palavras-chave
AML ×
Mostrar mais Palavras-chave
Índice
  1. 1. Estudo clínico
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

269 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

HEM

- 28/05/2015 - 1 Formulário, 5 Grupos de itens, 18 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, Record neutrophil count and specimen collection dates, Record chimerism assay data for marrow and/or blood, Marrow, T cell chimerism
HEM Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF1B0A30-0B37-31B9-E034-0003BA3F9857

Leukemia AML-AZA in elderly patients NCT00915252 - Remissionsstatus vor 2. Konsolidierung Leukämie AML AZA NCT00915252

- 22/05/2015 - 1 Formulário, 8 Grupos de itens, 44 Elementos de dados, 2 Idiomas
Grupos de itens: Patient data, Differential blood count, Bone marrow examination, Cytology, Cytogenetics, Molecular Genetic Analysis, Remission status, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML NCT00915252 5-Azacytidin plus Standardtherapie bei älteren AML-Patienten

AML AZA NCT00915252 - Remissionsstatus vor 1. Konsolidierung AML NCT00915252

- 20/05/2015 - 1 Formulário, 8 Grupos de itens, 44 Elementos de dados, 2 Idiomas
Grupos de itens: Patientendaten, Differentialblutbild, Knochenmarkuntersuchung, Zytologie, Zytogenetik, Molekulargenetik, Remission status, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML NCT00915252

AML - AZA (5-Azacytidin plus Standardtherapie bei älteren AML-Patienten) - Knochenmark-Diagnostik Tag 15

- 15/04/2015 - 1 Formulário, 4 Grupos de itens, 11 Elementos de dados, 2 Idiomas
Grupos de itens: Patientendaten, Knochenmarkuntersuchung, Zytologie, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML Principal Investigator Prof. Dr. Müller-Tidow

Infectiological Surveillance after HSCT - Department of Internal Medicine Knappschaftskrankenhaus Bochum-Langendreer - Infectiological Report 2 KKH Bochum SCT AML

- 08/04/2015 - 1 Formulário, 3 Grupos de itens, 5 Elementos de dados, 1 Idioma
Grupos de itens: Patient data, Request, Signature

Comorbidity score Sorror Score before Transplant HCT AML - Comorbidity Score Sorror Score before Transplant HCT AML

- 20/03/2015 - 1 Formulário, 1 Grupo de itens, 18 Elementos de dados, 1 Idioma
Grupo de itens: Comorbidity
Definitions of comorbidities included in the HCT-CI Original Paper can be found here: http://redbook.streamliners.co.nz/Sorror%20Comorbidity%20index%20in%20HCT.pdf

Hematology Form AML (E1900, NCT00049517)

- 21/01/2015 - 1 Formulário, 2 Grupos de itens, 22 Elementos de dados, 2 Idiomas
Grupos de itens: Header, Hematology lab
E1900 Hematology Form Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia NCT00049517 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A729522D-1C90-2FD4-E034-0003BA0B1A09

Long-Term Follow-up Form Leukemia (NCT00049517)

- 10/01/2015 - 1 Formulário, 8 Grupos de itens, 30 Elementos de dados, 1 Idioma
Grupos de itens: Header, Vital Status, Disease Follow-up Status, Relapse, New Primary, Toxicity, Non-Protocol Therapy, Transfusions
E1900 Long-Term Follow-up Form Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia NCT00049517 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A7294868-3C8F-2FCA-E034-0003BA0B1A09

Leukemia NCT00049517 Lab - E1900 Cover Page for Hematology Form - 2075140v3.0 - E1900 Cover Page for Hematology Form

- 09/01/2015 - 1 Formulário, 4 Grupos de itens, 12 Elementos de dados, 1 Idioma
Grupos de itens: Header, On Treatment, Off Treatment, CCRR MODULE
E1900 Cover Page for Hematology Form Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B19AB29D-AC61-25E1-E034-0003BA12F5E7

Leukemia NCT00049517 Toxicity - E1900 Cover Page for Adverse Event Form - 2075062v3.0 - E1900 Cover Page for Adverse Event Form

- 09/01/2015 - 1 Formulário, 4 Grupos de itens, 12 Elementos de dados, 1 Idioma
Grupos de itens: Header, On Treatment, Off Treatment, CCRR MODULE
E1900 Cover Page for Adverse Event Form Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B19AAD35-91C7-25DB-E034-0003BA12F5E7

Leukemia NCT00085124 Lab - CALGB: 10201 PERIPHERAL BLOOD AND BONE MARROW REPORT FORM - 2031273v3.0 - CALGB: 10201 PERIPHERAL BLOOD AND BONE MARROW REPORT FORM

- 09/01/2015 - 1 Formulário, 6 Grupos de itens, 43 Elementos de dados, 1 Idioma
Grupos de itens: CALGB Form, BONE MARROW, BONE MARROW DIFFERENTIAL, PERIPHERAL BLOOD DIFFERENTIAL, Degree of Dyspoiesis Present, CCRR MODULE
CALGB: 10201 PERIPHERAL BLOOD AND BONE MARROW REPORT FORM Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AD85FF2B-39F3-35D3-E034-0003BA12F5E7

NCT00049517 Follow-Up - E1900 Cover Page for Acute Leukemia Disease Assessment Form - 2075100v3.0 - E1900 Cover Page for Acute Leukemia Disease Assessment Form

- 09/01/2015 - 1 Formulário, 4 Grupos de itens, 12 Elementos de dados, 1 Idioma
Grupos de itens: Header, On Treatment, Off Treatment, CCRR MODULE
E1900 Cover Page for Acute Leukemia Disease Assessment Form Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B19AB05D-F815-25DE-E034-0003BA12F5E7

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial